How do I buy Allarity Therapeutics (ALLR) stock?

You can purchase shares of Allarity Therapeutics (NASDAQ:ALLR) through any online brokerage.View our list of the best stock brokerages

Who are Allarity Therapeutics (ALLR) competitors?

Other companies in Allarity Therapeutics’s space includes: Quoin Pharmaceuticals Ltd (NASDAQ:QNRX), Intensity Therapeutics Inc (NASDAQ:INTS), Cellectar Biosciences Inc (NASDAQ:CLRB), Nanoviricides Inc (AMEX:NNVC) and Lunai Bioworks Inc (NASDAQ:LNAI).

What is the forecast, or price target, for Allarity Therapeutics (ALLR) stock?

Allarity Therapeutics has a consensus price target of $9.50.

What is the current price for Allarity Therapeutics (ALLR)?

The stock price for Allarity Therapeutics (NASDAQ: ALLR) is $1.25 last updated January 23, 2026 at 7:05 PM EST.

Does Allarity Therapeutics (ALLR) pay a dividend?

There are no upcoming dividends for Allarity Therapeutics.

When is Allarity Therapeutics (NASDAQ:ALLR) reporting earnings?

Allarity Therapeutics does not have any upcoming earnings scheduled.

Is Allarity Therapeutics (ALLR) going to split?

There is no upcoming split for Allarity Therapeutics.

What sector and industry does Allarity Therapeutics (ALLR) operate in?

Allarity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Allarity Therapeutics (ALLR) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...

Comments